产品特点
1
PART IB - 1
SUMMARY OF PRODUCT CHARACTERISTICS
SEDAXYLAN
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Sedaxylan, 20 mg/ml
Solution for injection, for dogs, cats, horses and cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each millilitre contains:
ACTIVE SUBSTANCES:
Xylazine (base)
20.0 mg
Equivalent to 23.32 mg xylazine hydrochloride
EXCIPIENTS:
FUNCTION
AMOUNT
Methyl parahydroxybenzoate (E 218)
preservative
1.0 mg
Propyl parahydroxybenzoate (E 216)
preservative 0.1 mg
Propylene glycol
Co solvent
8.9 mg
For a full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Solution for injection
Clear and colourless.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats, horses and cattle.
4.2
INDICATION FOR USE
Sedation of dogs, cats, horses and cattle.
4.3
CONTRAINDICATIONS
Do not use in the later stages of pregnancy, see section 4.7
Do not use in animals with oesophageal obstruction, and torsion of the stomach, as the muscle
3
relaxant properties of the drug appear to accentuate the effects of the obstruction and because of
possible vomiting.
Do not use in animals with renal or hepatic impairment, respiratory dysfunction, cardiac
abnormalities, hypotension and/or shock. Do
not use in diabetic animals.
Do not use in calves younger than 1
week of age, foals younger than 2
weeks or in puppies and
kittens younger than 6 weeks. See also section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SP
阅读完整的文件